Joshua Bauml
Lung Cancer Das Leader @Johnson & Johnson Innovative Medicine
Philadelphia, PA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Jul 2024 — Present
Lung Cancer Das Leader @Johnson & Johnson Innovative Medicine
View department →
Spring House, PA, US
As the Lung Cancer DAS leader, I am responsible for the end-to-end Lung Cancer Development at Johnson and Johnson Innovative Medicines including mature assets (Rybrevant and lazertinib) as well as identifying new assets in early development and/or partnerships.
EDUCATION
2004 — 2008
Icahn School of Medicine at Mount Sinai
Doctor of Medicine (M.D.), Philosophy and Drama
2000 — 2004
Tufts University
Bachelor's degree
SKILLS
OncologyLung CancerMedicineInternal MedicineCancerClinical ResearchPublic SpeakingMolecular BiologyMedical EducationEpidemiologyHealthcare Information TechnologyClinical TrialsHead and Neck CancerBoard Certified
ABOUT JOSHUA BAUML
Vice President, Lung/H&N Cancer Disease Area Stronghold (DAS) Leader
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.